Mercury Laboratories has announced its financial results for the quarter.

The company reported a total income from operations of ₹15.96 Cr.

Net profit after tax for the period stood at ₹0.30 Cr.

Earnings per share were ₹2.48. These unaudited results were reviewed by the Audit Committee and approved by the Board.

The company operates solely in Pharmaceutical Products.

Full financial details are accessible on the company's website and stock exchange platforms.